CXCL10 and central nervous system cancer: Previous work has also demonstrated that endogenous CXCL10 could inhibit glioma development and promote tumor infiltration of CD8+ T cells in transgenic mice; additionally, myeloid-derived suppressor cells (MDSCs) produce CXCL10, indicating that they are pleiotropic [38, 41].